Charles K Gayer Biocryst Pharmaceuticals Inc (BCRX) insider trading activity

Charles K Gayer is Chief Commercial Officer of BIOCRYST PHARMACEUTICALS INC. Currently has a direct ownership of 307,533 shares of BCRX, which is worth approximately $2.24 Million. The most recent transaction as insider was on May 13, 2024, when has been sold 30,000 shares (Common Stock) at a price of $5.47 per share, resulting in proceeds of $164,100. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 308K

0% 3M change

25.21% 12M change

Total Value Held $2.24 Million

Charles K Gayer Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 13 2024	BUY Open market or private purchase	$164,100 $5.47 p/Share	30,000 Added 8.89%	307,533 Common Stock
Dec 19 2023	SELL Payment of exercise price or tax liability	$15,016 $6.05 p/Share	2,482 Reduced 0.9%	274,533 Common Stock
Dec 14 2023	SELL Payment of exercise price or tax liability	$37,551 $6.43 p/Share	5,840 Reduced 2.06%	277,015 Common Stock
Dec 14 2023	BUY Grant, award, or other acquisition	-	34,000 Added 10.73%	282,855 Common Stock
Dec 19 2022	BUY Grant, award, or other acquisition	-	34,000 Added 12.16%	245,610 Common Stock
Dec 15 2022	SELL Open market or private sale	$66,490 $10.9 p/Share	6,100 Reduced 2.8%	211,610 Common Stock
Dec 14 2021	BUY Grant, award, or other acquisition	-	125,000 Added 32.34%	261,556 Common Stock

CKG

Charles K Gayer

Chief Commercial Officer

Durham, NC

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BCRX shares.

Notify only if

Value

Insider Trading

Get notified when an Biocryst Pharmaceuticals Inc insider buys or sells BCRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to BIOCRYST PHARMACEUTICALS INC

Track Activities on BCRX

Account